Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BATTLECREEK Largest Shipment Since 20th-Century-Fox TWELVE in 2011
Quote:
How major? Well - based on video preorders already received from Walmart, Target, Best Buy, K-Mart and Family Video - BATTLECREEK will be the largest new release video shipment since 20th Century Fox Home Video shipped over 250,000 units of "TWELVE" for HHSE back in January, 2011. Because of what happened THIS WEEKEND with BATTLECREEK in theatres, HHSE will have our biggest December ever.
\
Monday, November 6, 2017
Battlecreek Theatrical Launch - meeting and exceeding our ancillary commitments!
Greetings HHSE Friends & Followers - Friday (Nov. 3), marked the launch of BATTLECREEK into 27 theatres in 18 different markets across the USA.
Some shareholders have expressed the need for a clarification blog as to why HHSE has released BATTLECREEK to only 27 theatres and an explanation of the manner pursued - in hopes that this information will illuminate the overall ancillary business model for those who are unfamiliar with the film industry.
What is the rationale for doing a limited theatrical release with limited advertising support? Isn't that a guarantee that a film will not hit a good box office number?
Yes, that's correct. Perhaps blindingly obvious to those who understand our strategy. If our 27 theatres playing BATTLECREEK had SOLD OUT EVERY SEAT FOR EVERY SHOWTIME this past weekend, we might have grossed about $200,000 - because unlike a film such as THOR which played in large auditoriums, smaller indie releases are usually in 60-to-90 seat auditoriums, and often "split" (shared auditorium) with another indie release. But we didn't sell out all of our shows and we didn't hit $200,000. We generated about $30,000 - and will likely finish the first week with about $45,000 in box office gross.
So, why spend $35,000 in "hard costs" plus $15,000 in "deferred fees" in pursuit of only $45,000 in total box office grosses (that will "settle" out after the theatres keep their share to about $20,000 back to HHSE)? The math from box office returns alone does not seem sustainable. That's correct. It's not a logical venture until you see the massive impact this sort of theatrical release delivers for all other ancillary revenue streams.
Our goal with BATTLECREEK was to enhance the visibility and credibility of the film so that we could MAXIMIZE overall revenues for HHSE. By opening the film in "at least 8-of the top 25 largest markets" we qualified the film for NATIONAL TV coverage - elevated its stature for home video - positioned the film for a lucrative Netflix contract - qualified the film for a Redbox kiosk placement - and legitimized the film for international markets. From a modest investment, we reap major returns.
How major? Well - based on video preorders already received from Walmart, Target, Best Buy, K-Mart and Family Video - BATTLECREEK will be the largest new release video shipment since 20th Century Fox Home Video shipped over 250,000 units of "TWELVE" for HHSE back in January, 2011. Because of what happened THIS WEEKEND with BATTLECREEK in theatres, HHSE will have our biggest December ever.
Will HHSE ever have a movie that has more significant box office potential? Absolutely - in fact,,we have solid indications that our Dec. 1 release of DAISY WINTERS could have that special "spark" with holiday movie audiences. If it does, great. If it does not, still great, because we are spending theatrical funds conservatively and in a targeted manner so that we are NOT dependent on box office magic to thrive. Meanwhile, national TV audiences have ALREADY seen feature stories on BATTLECREEK on ACCESS HOLLYWOOD, ENTERTAINMENT TONIGHT and EXTRA. Tomorrow morning, ALISON EASTWOOD is slated for FOX AND FRIENDS and HOME AND FAMILY (Hallmark Channel)... major national TV placements that would NOT occur for a "direct-to-video" release... but are available for theatrical titles... and ironically DRIVE the home video demand.
Successfully releasing independent films is a strategy and process involving multiple revenues streams and steps to achieve the best, bottom-line result. We are happy with the launch of BATTLECREEK, and know that our year-end financials will demonstrate the validity of this strategy.
http://hannoverhousemovies.blogspot.com/2017/11/battlecreek-theatrical-launch-meeting.html ;
HHSE
2018 Major Activities Blog Bullet Points, Highlights, Summary
Saturday, December 23, 2017
* Re-focus HHSE Primary Activities & Revenue Streams
* HHSE Unique OTC Pinksheet. Operating/Reporting/Profitable.
* "One Film Away" from Major Independent Studio
* Impressive Slate of Titles for 2018 and 2019
* Two Terrific Distribution Partners
a.) Cinedigm Entertainment
b.) Sony Pictures Home Entertainment
* Direct Relationships With all of the Major Theatre Exhibition Chains.
* Re-focused Theatrical Release Model is Delivering Huge Benefits to our Ancillary Revenues.
* VODwiz Streaming Venture Partnerships Providing Access to Indie Labels.
* No Dilution 2.5 years (none coming)
* Release Activities First Half 2018:
- Jan - Theatrical - "BLOODFEAST"
- Feb 9 - Theatrical - "DEATH HOUSE"
- Feb 6 - Massive Placement DVD "BATTLECREEK"
- April- Three Titles Releases Sony (including "DAISY WINTERS")
- May - Theatrical - "THE RIOT ACT"
- May - DVD - Cinedigm - "THE LENNON PROJECT"
- "MUSE"
- "INSOMNIUM"
- "IDENTITY CRISIS"
- "SLEEP CELL"
- "DINOSAURS OF THE JURASSIC"
- "SACRED HEARTS"
2016, 2017 Financial Audits
Form 10 Registration
HHSE UPLIST OTCQB
HHSE Chart: Market Cap, Shares in Issue Analyssis
More HHSE Blog(s) & News Coming over Holiday and First Week January
HAPPY HOLIDAYS
HHSE
WHERE'S THE DRAGON - With the dissolution of the merger between HHSE and Crimson Forest, the company is finally cleared to revert back to the terms of the Dec. 2016 distribution agreement for this title. Accordingly, on February 3, 2018, this enchanting Animated Feature will be released to theatres in key markets, in advance of a May, 2018 Home Video and V.O.D. launch.
GETTING GRACE - Hot on the heels of a major NYC Market festival SWEEP of all major awards, HHSE will be releasing this Faith-Based Comedy-Drama nationwide on February 10, 2018 - with an outreach campaign that includes mega-churches and a key-market BUS TOUR with star and director DANIEL ROEBUCK ("Matlock", "The Fugitive") to drive local market enthusiasm
THE RIOT ACT is based on the true story of romance, murder and revenge that occurred at the Van Buren Opera House in 1903. The film is planned for an APRIL 27, 2018 Theatrical Release
BLOODFEAST - Now that the MPAA has approved our fourth edit for "R-Rating Status" - we can FINALLY get mainstream theatres to book this picture. To be released in January...
''DEATH HOUSE'' from writer-director B. Harrison Smith. The horror-thriller features an all-star cast of genre' superstars and will open on approximately one-hundred theatres in top USA markets beginning February 23, 2018.
''DEATH HOUSE'' takes place in a secret, maximum security prison populated by a horrific crew of extremely dangerous inmates. When an unexpected power outage sets the prisoners free, a group of visiting VIPs must scramble for their lives. The film was co-written by the legendary Gunnar Hansen, of ''Texas Chainsaw Massacre Fame,'' and was produced by Rick Finkelstein (''Area 407'', ''Garlic and Gunpowder'') and Steven Chase (''Garlic and Gunpowder''). Principal cast members include Kane Hodder (''Monster'', ''2001 Maniacs''), Dee Wallace (''E.T.''), Adrienne Barbeau (''Swamp Thing''), Sid Haig (''Devil's Rejects''), Michael Berryman (''The Hills Have Eyes''), Tony Todd (''Candyman'') and Lindsay Hartley (''Smallville'').
Other notable cast members include Barbara Crampton, Bill Mosley, Lloyd Kaufman, R.A. Mihailoff, Vincent Ward, Richard Speight, Jr., Beverly Randolf, Debbie Rachon and Felissa Rose.
Red-carpet theatrical events will be open to the public and will occur in both Los Angeles (Thursday, Feb. 22) and New York City (Friday, Feb. 23), with many cast members and principal production team present. Theatrical exhibitors will include Regal Entertainment Group, Cinemark / Century Group, Malco Theatres, Harkins, Marcus, B&B and Megaplex Theatres.
''We share the horror-industry's enthusiasm for the release of this film,'' said Hannover House C.E.O. Eric Parkinson. ''The concept of a film featuring the all-star cast of stars from some of the biggest horror-hits in recent decades is brilliant, and Harrison, Rick, Steven and the entire production team have delivered a truly enjoyable result. We believe that audiences will love this film, as has already been indicated through word-of-mouth and pre-screenings.''
The initial theatrical release from Hannover House is expected to reach approximately one-hundred theatres in most of the top 40 largest DMA markets in the country. The home video release and video-on-demand release are planned for June through a distribution pact with Sony Pictures Home Entertainment.
HHSE VODWIZ welcomes Production Master Technician EARL HALE to our Team!
Greetings Hannover House Friends & Followers - Just in time for the Holidays, we are pleased to announce the engagement of EARL HALE as Technical Services Director for VODWIZ and Hannover House. Earl has an impressive resume in video production, mastering and technical services, including multi-year directorships at Walmart TV and the Media Center of the University of Arkansas Global Campus. A formal press release will post in early January, along with VODWIZ supplier and status news.
GOOD PRODUCT SELLS - U.S. Theatrical Exhibitors and Video Retailers have proven that they WILL strongly support "quality" films with production values, recognized stars and good performances. Case in point: our tiny theatrical release of "BATTLECREEK" has now sparked RECORD home video pre-orders for Hannover House - with placements at WALMART, TARGET, BEST BUY, FAMILY VIDEO and "awaiting" final approval from REDBOX. This is the first HHSE video heavily supported by TARGET in five years! Our advanced-buzz for "DAISY WINTERS" suggests even more impressive results are likely to follow!
VODwiz - Online Independent Films Streaming Portal
- a.) Doubled Titles Library (Second only to Amazon at this point).
- b.) Partnered with Amazon the World's Leading Digital Services Operator.
New Ventures - With Sony and Cinedigm handling selected HHSE releases, our management time can be redirected towards theatrical releases, higher-end acquisitions (including productions) and our VODWIZ streaming venture. As will be seen in our 2017 filings, theatrical release activities are the engine that is now driving HHSE revenues in all other arenas. Theatrical titles get more shelf space and priority placement when released to home video; theatrical titles get larger license fees from Netflix and Television licensors; and theatrical titles provide two direct revenue streams for HHSE in the form of both servicing fees and revenue participations. The current mass merchant and key video retail support for "BATTLECREEK" evidences the sales boost that a targeted, limited theatrical release can deliver for the subsequent home video release.
HHSE WHAT IS OUR PLAN FOR GROWTH IN 2018 AND
BEYOND?
* We believe that HHSE is "one film away" from being a major independent studio. All it takes is any one of the many titles in our current release queue to become a surprise box officer performer such as "Lady Bird" or "Get Out" and we are suddenly a $100-MM company.
* We have an impressive slate of titles for 2018 and 2019 - and two terrific distribution partners for North America (Cinedigm Entertainment and Sony Pictures Home Entertainment) - as well as our direct relationships with all of the major theatre exhibition chains. Our "lower-end" titles are much higher profile than in past years... and our higher-end titles are now genuine theatrical caliber contenders. We are positioned for the proverbial lucky break that happens when the right film is released at the right time...
* Our recently re-focused Theatrical Release model is delivering huge benefits to our ancillary revenues... and our new partnerships with indie labels is providing access for the VODWIZ streaming venture, which truly could become "the tail that wagged the dog" for HHSE shareholders.
HHSE WHAT IS OUR PLAN FOR GROWTH IN 2018 AND
BEYOND?
* We believe that HHSE is "one film away" from being a major independent studio. All it takes is any one of the many titles in our current release queue to become a surprise box officer performer such as "Lady Bird" or "Get Out" and we are suddenly a $100-MM company.
* We have an impressive slate of titles for 2018 and 2019 - and two terrific distribution partners for North America (Cinedigm Entertainment and Sony Pictures Home Entertainment) - as well as our direct relationships with all of the major theatre exhibition chains. Our "lower-end" titles are much higher profile than in past years... and our higher-end titles are now genuine theatrical caliber contenders. We are positioned for the proverbial lucky break that happens when the right film is released at the right time...
* Our recently re-focused Theatrical Release model is delivering huge benefits to our ancillary revenues... and our new partnerships with indie labels is providing access for the VODWIZ streaming venture, which truly could become "the tail that wagged the dog" for HHSE shareholders.
Release Activities: January will see the theatrical release of "BLOODFEAST" - delayed since July due to MPAA re-cut needs. February will see a massive placement of DVDs and BluRays for "BATTLECREEK" (street date Feb. 6). That same week, on Friday (Feb. 9), HHSE will commence the initial theatrical launch of "DEATH HOUSE" to theatres. In April, three titles will be released via Sony Pictures Home Entertainment (including "DAISY WINTERS"); in May, HHSE will release "THE RIOT ACT" to theatres and Cinedigm will release DVD's and BluRays of "THE LENNON PROJECT" for the Company. Other titles in queue for theatrical and / or home video during the first half of 2018 include "MUSE", "INSOMNIUM", "IDENTITY CRISIS", "SLEEPER CELL", "DINOSAURS OF THE JURASSIC" and "SACRED HEARTS" (all but the last title were planned for 2017, but delayed during the Crimson merger pursuit).
Corporate Governance: HHSE will be re-filing a Form 10 Registration with two full years of audits (2016 and 2017) early this coming year, during the first few weeks; the CPA review is already underway and much of the documentation and procedural steps for the audit were already assembled during 2017 while planning for the Crimson merger. We feel that a registration of the shares and the subsequent uplist to OTC:QB will attract more investors and some institutional funds... resulting in a higher anticipated daily trading volume, and a predicted much higher HHSE stock price (based on business results, industry fundamentals and the proven power of Shareholder Enthusiasm).
It Doesn't Take Much to Double or Triple the HHSE Share Price - Look at the market-cap spike for HHSE stock earlier this year (seen as June, 2017). This increase in PPS was due to shareholder excitement about the prospect that a merger with Crimson Forest would provide HHSE with high-profile films to distribute. The growth in PPS was not based on any increase in revenues (in fact, the time-distraction of the Crimson merger caused many 2017 releases to be delayed). The PPS spike was driven solely by enthusiasm.
"we do NOT need to dilute our shareholders by 42% (or any amount) in order to become fully registered and uplisted."
NO DILUTION for 2.5 YEARS
HHSE Hannover House Pacts with Entertainment Factory for Release of Epic Horror Feature, DEATH HOUSE
LOS ANGELES, CA / ACCESSWIRE / December 29, 2017 / Indie distributor Hannover House, Inc., (OTC PINK: HHSE) and theatrical subsidiary Medallion Releasing, Inc. have entered into an agreement with South Florida-based Entertainment Factory for a national theatrical release of ''DEATH HOUSE'' from writer-director B. Harrison Smith. The horror-thriller features an all-star cast of genre' superstars and will open on approximately one-hundred theatres in top USA markets beginning February 23, 2018.
''DEATH HOUSE'' takes place in a secret, maximum security prison populated by a horrific crew of extremely dangerous inmates. When an unexpected power outage sets the prisoners free, a group of visiting VIPs must scramble for their lives. The film was co-written by the legendary Gunnar Hansen, of ''Texas Chainsaw Massacre Fame,'' and was produced by Rick Finkelstein (''Area 407'', ''Garlic and Gunpowder'') and Steven Chase (''Garlic and Gunpowder''). Principal cast members include Kane Hodder (''Monster'', ''2001 Maniacs''), Dee Wallace (''E.T.''), Adrienne Barbeau (''Swamp Thing''), Sid Haig (''Devil's Rejects''), Michael Berryman (''The Hills Have Eyes''), Tony Todd (''Candyman'') and Lindsay Hartley (''Smallville'').
Other notable cast members include Barbara Crampton, Bill Mosley, Lloyd Kaufman, R.A. Mihailoff, Vincent Ward, Richard Speight, Jr., Beverly Randolf, Debbie Rachon and Felissa Rose.
Red-carpet theatrical events will be open to the public and will occur in both Los Angeles (Thursday, Feb. 22) and New York City (Friday, Feb. 23), with many cast members and principal production team present. Theatrical exhibitors will include Regal Entertainment Group, Cinemark / Century Group, Malco Theatres, Harkins, Marcus, B&B and Megaplex Theatres.
''We share the horror-industry's enthusiasm for the release of this film,'' said Hannover House C.E.O. Eric Parkinson. ''The concept of a film featuring the all-star cast of stars from some of the biggest horror-hits in recent decades is brilliant, and Harrison, Rick, Steven and the entire production team have delivered a truly enjoyable result. We believe that audiences will love this film, as has already been indicated through word-of-mouth and pre-screenings.''
The initial theatrical release from Hannover House is expected to reach approximately one-hundred theatres in most of the top 40 largest DMA markets in the country. The home video release and video-on-demand release are planned for June through a distribution pact with Sony Pictures Home Entertainment.
For more information, contact: Desiree Garnier, Desiree@HannoverHouse.com, 479-283-8318.
Death House Title Fact Sheet
TITLE:
DEATH HOUSE
GENRE:
HORROR
RUNNING TIME:
93-Minutes
MPAA RATING:
Rated ''R'' for strong horror violence and gore throughout, language, sexual reference and nudity.
FORMAT:
DCP (JPEG-2000), 1:1.85 Aspect Ratio, Dolby Stereo;
DIRECTOR:
HARRISON SMITH (''Camp Dread'', ''The Fields'');
WRITERS:
GUNNAR HANSEN (''Texas Chain Saw Massacre'');
HARRISON SMITH (''Garlic and Gunpowder'', ''360 Degrees of Hell'');
PRODUCERS:
RICK FINKELSTEIN (''Area 407'', ''Garlic and Gunpowder'');
STEVEN CHASE (''Garlic and Gunpowder'', ''Bus Driver'');
STARS:
KANE HODDER (''Monster'', ''2001 Maniacs'')
DEE WALLACE - ''E.T.'', ''Critters'', ''Cujo'', ''Extraordinary Measures''
LINDSAY HARTLEY - ''Smallville'', ''All My Children''
ADRIENNE BARBEAU - ''Escape from New York'', ''The Fog''
MICHAEL BERRYMAN - ''The Hills Have Eyes'', ''Weird Science''
VERNON WELLS - ''The Road Warrior'', ''Commando'', ''Inner Space''
SID HAIG - ''House of 1000 Corpses'', ''The Devil's Rejects''
TONY TODD - ''Candyman'', ''The Crow'', ''The Man from Earth''
SYNOPSIS:
During an exclusive tour, a power breakdown inside a secret, maximum security prison known as the Death House sends two agents fighting through a labyrinth of horrors while being pursued by a ruthless army of roaming inmates. As they fight to escape, the agents push toward the lowest depths of the facility where they learn a supernatural group of evil beings are their only chance for survival.
DISTRIBUTOR: Hannover House, Inc.
THEATRICAL RELEASE: Friday, February 23, 2018
LOCATION COUNT: Approximately One-Hundred (100) screens in top markets.
OFFICIAL WEBSITE: http://www.DeathHouse.us
LINK TO UNRATED TRAILER:
The Board believes that Fully Registered Shares will be more attractive to HHSE program suppliers and investors - as well as to institutional investors and hedge funds - and that pursuing these activities now is a good use of ongoing cash flows
It Doesn't Take Much to Double or Triple the HHSE Share Price - Look at the market-cap spike for HHSE stock earlier this year (seen as June, 2017). This increase in PPS was due to shareholder excitement about the prospect that a merger with Crimson Forest would provide HHSE with high-profile films to distribute. The growth in PPS was not based on any increase in revenues (in fact, the time-distraction of the Crimson merger caused many 2017 releases to be delayed). The PPS spike was driven solely by enthusiasm.
HHSE Corporate Governance: HHSE will be re-filing a Form 10 Registration with two full years of audits (2016 and 2017) early this coming year, during the first few weeks; the CPA review is already underway and much of the documentation and procedural steps for the audit were already assembled during 2017 while planning for the Crimson merger. We feel that a registration of the shares and the subsequent uplist to OTC:QB will attract more investors and some institutional funds... resulting in a higher anticipated daily trading volume, and a predicted much higher HHSE stock price (based on business results, industry fundamentals and the proven power of Shareholder Enthusiasm).
HHSE Corporate Governance: HHSE will be re-filing a Form 10 Registration with two full years of audits (2016 and 2017) early this coming year, during the first few weeks; the CPA review is already underway and much of the documentation and procedural steps for the audit were already assembled during 2017 while planning for the Crimson merger. We feel that a registration of the shares and the subsequent uplist to OTC:QB will attract more investors and some institutional funds... resulting in a higher anticipated daily trading volume, and a predicted much higher HHSE stock price (based on business results, industry fundamentals and the proven power of Shareholder Enthusiasm).
HHSE Corporate Governance: HHSE will be re-filing a Form 10 Registration with two full years of audits (2016 and 2017) early this coming year, during the first few weeks; the CPA review is already underway and much of the documentation and procedural steps for the audit were already assembled during 2017 while planning for the Crimson merger. We feel that a registration of the shares and the subsequent uplist to OTC:QB will attract more investors and some institutional funds... resulting in a higher anticipated daily trading volume, and a predicted much higher HHSE stock price (based on business results, industry fundamentals and the proven power of Shareholder Enthusiasm).
HHSE Release Activities: January will see the theatrical release of "BLOODFEAST" - delayed since July due to MPAA re-cut needs. February will see a massive placement of DVDs and BluRays for "BATTLECREEK" (street date Feb. 6). That same week, on Friday (Feb. 9), HHSE will commence the initial theatrical launch of "DEATH HOUSE" to theatres. In April, three titles will be released via Sony Pictures Home Entertainment (including "DAISY WINTERS"); in May, HHSE will release "THE RIOT ACT" to theatres and Cinedigm will release DVD's and BluRays of "THE LENNON PROJECT" for the Company. Other titles in queue for theatrical and / or home video during the first half of 2018 include "MUSE", "INSOMNIUM", "IDENTITY CRISIS", "SLEEPER CELL", "DINOSAURS OF THE JURASSIC" and "SACRED HEARTS" (all but the last title were planned for 2017, but delayed during the Crimson merger pursuit).
HHSE Release Activities: January will see the theatrical release of "BLOODFEAST" - delayed since July due to MPAA re-cut needs. February will see a massive placement of DVDs and BluRays for "BATTLECREEK" (street date Feb. 6). That same week, on Friday (Feb. 9), HHSE will commence the initial theatrical launch of "DEATH HOUSE" to theatres. In April, three titles will be released via Sony Pictures Home Entertainment (including "DAISY WINTERS"); in May, HHSE will release "THE RIOT ACT" to theatres and Cinedigm will release DVD's and BluRays of "THE LENNON PROJECT" for the Company. Other titles in queue for theatrical and / or home video during the first half of 2018 include "MUSE", "INSOMNIUM", "IDENTITY CRISIS", "SLEEPER CELL", "DINOSAURS OF THE JURASSIC" and "SACRED HEARTS" (all but the last title were planned for 2017, but delayed during the Crimson merger pursuit).
HHSE Release Activities: January will see the theatrical release of "BLOODFEAST" - delayed since July due to MPAA re-cut needs. February will see a massive placement of DVDs and BluRays for "BATTLECREEK" (street date Feb. 6). That same week, on Friday (Feb. 9), HHSE will commence the initial theatrical launch of "DEATH HOUSE" to theatres. In April, three titles will be released via Sony Pictures Home Entertainment (including "DAISY WINTERS"); in May, HHSE will release "THE RIOT ACT" to theatres and Cinedigm will release DVD's and BluRays of "THE LENNON PROJECT" for the Company. Other titles in queue for theatrical and / or home video during the first half of 2018 include "MUSE", "INSOMNIUM", "IDENTITY CRISIS", "SLEEPER CELL", "DINOSAURS OF THE JURASSIC" and "SACRED HEARTS" (all but the last title were planned for 2017, but delayed during the Crimson merger pursuit).
HHSE WHAT IS OUR PLAN FOR GROWTH IN 2018 AND
BEYOND?
* We believe that HHSE is "one film away" from being a major independent studio. All it takes is any one of the many titles in our current release queue to become a surprise box officer performer such as "Lady Bird" or "Get Out" and we are suddenly a $100-MM company.
* We have an impressive slate of titles for 2018 and 2019 - and two terrific distribution partners for North America (Cinedigm Entertainment and Sony Pictures Home Entertainment) - as well as our direct relationships with all of the major theatre exhibition chains. Our "lower-end" titles are much higher profile than in past years... and our higher-end titles are now genuine theatrical caliber contenders. We are positioned for the proverbial lucky break that happens when the right film is released at the right time...
* Our recently re-focused Theatrical Release model is delivering huge benefits to our ancillary revenues... and our new partnerships with indie labels is providing access for the VODWIZ streaming venture, which truly could become "the tail that wagged the dog" for HHSE shareholders.
HHSE WHAT IS OUR PLAN FOR GROWTH IN 2018 AND
BEYOND?
* We believe that HHSE is "one film away" from being a major independent studio. All it takes is any one of the many titles in our current release queue to become a surprise box officer performer such as "Lady Bird" or "Get Out" and we are suddenly a $100-MM company.
* We have an impressive slate of titles for 2018 and 2019 - and two terrific distribution partners for North America (Cinedigm Entertainment and Sony Pictures Home Entertainment) - as well as our direct relationships with all of the major theatre exhibition chains. Our "lower-end" titles are much higher profile than in past years... and our higher-end titles are now genuine theatrical caliber contenders. We are positioned for the proverbial lucky break that happens when the right film is released at the right time...
* Our recently re-focused Theatrical Release model is delivering huge benefits to our ancillary revenues... and our new partnerships with indie labels is providing access for the VODWIZ streaming venture, which truly could become "the tail that wagged the dog" for HHSE shareholders.
OTCQB = AUDITED FINANCIALS
Go HHSE!
OTC.PINK = NO AUDITED FINANCIALS
Go HHSE!
NO DILUTION for 2.5 YEARS
"we do NOT need to dilute our shareholders by 42% (or any amount) in order to become fully registered and uplisted."
LOTS TO BE UNLEASHED IN COMING FEW WEEKS!!!!!!!!!!!!!!!
Corporate Governance: HHSE will be re-filing a Form 10 Registration with two full years of audits (2016 and 2017) early this coming year, during the first few weeks; the CPA review is already underway and much of the documentation and procedural steps for the audit were already assembled during 2017 while planning for the Crimson merger. We feel that a registration of the shares and the subsequent uplist to OTC:QB will attract more investors and some institutional funds... resulting in a higher anticipated daily trading volume, and a predicted much higher HHSE stock price (based on business results, industry fundamentals and the proven power of Shareholder Enthusiasm).
WHAT IS OUR PLAN FOR GROWTH IN 2018 AND BEYOND?
* We believe that HHSE is "one film away" from being a major independent studio. All it takes is any one of the many titles in our current release queue to become a surprise box officer performer such as "Lady Bird" or "Get Out" and we are suddenly a $100-MM company.
* We have an impressive slate of titles for 2018 and 2019 - and two terrific distribution partners for North America (Cinedigm Entertainment and Sony Pictures Home Entertainment) - as well as our direct relationships with all of the major theatre exhibition chains. Our "lower-end" titles are much higher profile than in past years... and our higher-end titles are now genuine theatrical caliber contenders. We are positioned for the proverbial lucky break that happens when the right film is released at the right time...
* Our recently re-focused Theatrical Release model is delivering huge benefits to our ancillary revenues... and our new partnerships with indie labels is providing access for the VODWIZ streaming venture, which truly could become "the tail that wagged the dog" for HHSE shareholders.
It Doesn't Take Much to Double or Triple the HHSE Share Price - Look at the market-cap spike for HHSE stock earlier this year (seen as June, 2017). This increase in PPS was due to shareholder excitement about the prospect that a merger with Crimson Forest would provide HHSE with high-profile films to distribute. The growth in PPS was not based on any increase in revenues (in fact, the time-distraction of the Crimson merger caused many 2017 releases to be delayed). The PPS spike was driven solely by enthusiasm.
Release Activities: January will see the theatrical release of "BLOODFEAST" - delayed since July due to MPAA re-cut needs. February will see a massive placement of DVDs and BluRays for "BATTLECREEK" (street date Feb. 6). That same week, on Friday (Feb. 9), HHSE will commence the initial theatrical launch of "DEATH HOUSE" to theatres. In April, three titles will be released via Sony Pictures Home Entertainment (including "DAISY WINTERS"); in May, HHSE will release "THE RIOT ACT" to theatres and Cinedigm will release DVD's and BluRays of "THE LENNON PROJECT" for the Company. Other titles in queue for theatrical and / or home video during the first half of 2018 include "MUSE", "INSOMNIUM", "IDENTITY CRISIS", "SLEEPER CELL", "DINOSAURS OF THE JURASSIC" and "SACRED HEARTS" (all but the last title were planned for 2017, but delayed during the Crimson merger pursuit).
New Ventures - With Sony and Cinedigm handling selected HHSE releases, our management time can be redirected towards theatrical releases, higher-end acquisitions (including productions) and our VODWIZ streaming venture. As will be seen in our 2017 filings, theatrical release activities are the engine that is now driving HHSE revenues in all other arenas. Theatrical titles get more shelf space and priority placement when released to home video; theatrical titles get larger license fees from Netflix and Television licensors; and theatrical titles provide two direct revenue streams for HHSE in the form of both servicing fees and revenue participations. The current mass merchant and key video retail support for "BATTLECREEK" evidences the sales boost that a targeted, limited theatrical release can deliver for the subsequent home video release.
FORM 10, AUDIT, UPLIST - STARTING JANUARY 2018